Reneuron Share Discussion Threads

[madengland] 13/5/2015 07:14

If it's one entity they've taken around 10% of company so we can expect an RNS over the next few days

[madengland] 13/5/2015 07:00

Those trades have taken a while to work through, intrigued to know who took them

[stewart_25] 12/5/2015 19:06

So two big trades and no movement in price ?

[madengland] 12/5/2015 18:55

Yeah very big numbers..... Think we will know soon. Anyone got Neil's number, he will know

[peawacks] 12/5/2015 17:46

Some big stuff there, Mad !


16:30 5.30p 100,000 £5,300 Sell O
16:28 5.44p 70,000 £3,808 Buy O
16:25 5.45p 25,000 £1,362 Buy O
16:25 5.45p 35,000 £1,908 Buy O
16:12 5.28p 1,790 £94 Sell O
16:12 5.28p 100,000 £5,275 Sell O
16:12 5.36p 55,737 £2,988 Buy O
16:11 5.36p 29,725 £1,592 Buy O
16:05 5.36p 2,688 £144 Buy O
16:00 5.25p 70,700,000 £3,711,750 Unknown O
15:59 5.33p 84,268 £4,492 Buy O
15:56 5.22p 9,000 £470 Sell O
15:53 5.33p 10,000 £533 Buy O
15:52 5.25p 70,000,000 £3,675,000 Unknown O
15:50 5.33p 30,000 £1,599 Buy O

[stewart_25] 12/5/2015 17:27

40p would be lovely

[madengland] 12/5/2015 16:42

I wonder how much a big player would value the potential of these drugs? 10p, 20p, 40p?

[madengland] 12/5/2015 16:35

Yes someone likes this. Let's hope it's not bought out before its potential is realised. Looks so promising!

[bigspuds] 12/5/2015 12:24

big buyers continue to flood in

[deltar] 12/5/2015 10:52

One hospital bed costs the nhs about 150,000 pounds a year and there were c140,000 beds in 2014.

Stroke patients occupy around 20 per cent of all acute hospital beds and 25 per cent of long term beds.

Each year in England, approximately 110,000 people have a first or recurrent stroke and a further 20,000 people have a transient ischaemic attack (TIA). More than 900,000 people in England are living with the effects of stroke, and half of these are dependent on other people for help with everyday activities.
In England, stroke is estimated to cost the economy around £7 billion per year. This comprises direct costs to the NHS of £2.8 billion (around £5.5 million per 100,000 population), costs of informal care of £2.4 billion and costs because of lost productivity and disability of £1.8 billion.

[madengland] 10/5/2015 09:02

Yes this is looking really promising.....let's see a bit more good news.

[deltar] 08/5/2015 17:00

Well worth the wait!!

[bigspuds] 08/5/2015 16:03

strong into the close, big buyers out still.

[stewart_25] 08/5/2015 13:50

looking better - onwards and upwards...

[bonzo] 08/5/2015 13:06

5mill trade..??

[madengland] 08/5/2015 10:33

Hmm wonder when some more encouraging news will project this higher.... #woodfordknowsvalue

[madengland] 07/5/2015 17:22

New 52 week closing high. Nicely does it. Had just over 200k this morning, this feels under the radar still

[bigspuds] 07/5/2015 15:41

Someone still taking hefty chunks at top dollar

[rayrac] 07/5/2015 10:00

I know I might be accused of 'pushing' TRX here and I do hold the shares, but they report on the 11th I believe? So watch the birdie there, it could be interesting, if not then, then later.

I keep buying into the biotechs/medics, even though I'm a past holder of British Biotech. I didn't actually come to harm there, as I sold down as their shares went up, only to fall on their so called, cancer wonder drug, falling at the last hurdle!

You can't win them all?

[madengland] 07/5/2015 07:48

Thanks I will take a look

[rayrac] 07/5/2015 07:46

I mentioned TRX earlier here. Woodford holds 15% of that.

I'm inclined to follow him in both! He has a good reputation to protect!!

[madengland] 07/5/2015 07:17

NW likes this share.... 21% and growing. Maybe it's unloved from past history and he sniffs a bargain

[bonzo] 06/5/2015 17:04

Useful reassurance

The European Court of Justice (ECJ) – consisting of a full chamber of 13 judges, as opposed to the customary five – has handed down a landmark decision in relation to the patentability of stem cells in Europe. The ECJ ruled that parthenotes (unfertilised human eggs which have been stimulated to divide in the absence of sperm) are not classed as “human embryos” within the meaning of the EC Biotech Directive1 (the Directive) and, therefore, can be patented.

A small relief to ReNeuron I am sure.

[stewart_25] 05/5/2015 09:05

if he is looking at 20p plus i would be happy with that!!!

[madengland] 05/5/2015 08:18

I would love to know what price Woodford is hoping to sell his 20% stake to a large pharma for.....